Nivel de conocimiento del uso de Nitazoxanida e Ivermectina como tratamiento para Covid-19 en consumidores de la botica “Tu Botic@.com” Huacho - 2022
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Privada de Huancayo Franklin Roosevelt
DOI
Abstract
El presente trabajo de investigación tiene como objetivo general identificar el nivel de conocimiento del uso de la Nitazoxanida e Ivermectina en el tratamiento de COVID-19 en los usuarios de la botica “Tu Botic@.com”, Huacho 2022. La investigación es de tipo no experimental, descriptivo, observacional y transversal porque se estudia en un tiempo y población definida.
El conocimiento del uso de la Nitazoxanida en el tratamiento de COVID-19 es en un 67% bajo, lo que indica que los participantes desconocen sobre este medicamento. El conocimiento del uso de la Ivermectina en el tratamiento de COVID-19 es alto en un 43.1% de los participantes y medio en un 21.7% lo que indica que los participantes conocen sobre este medicamento.
The general objective of this research is to identify the level of knowledge of the use of Nitazoxanide and Ivermectin in the treatment of COVID-19 in the users of the pharmacy "Tu Botic@.com", Huacho 2022. The research is non-experimental, descriptive, observational and cross-sectional because it is studied in a defined time and population. The knowledge of the use of Nitazoxanide in the treatment of COVID-19 is 67% low, which indicates that the participants do not know about this drug. The knowledge of the use of Ivermectin in the treatment of COVID-19 is high in 43.1% of the participants and medium in 21.7% indicating that the participants know about this drug.
The general objective of this research is to identify the level of knowledge of the use of Nitazoxanide and Ivermectin in the treatment of COVID-19 in the users of the pharmacy "Tu Botic@.com", Huacho 2022. The research is non-experimental, descriptive, observational and cross-sectional because it is studied in a defined time and population. The knowledge of the use of Nitazoxanide in the treatment of COVID-19 is 67% low, which indicates that the participants do not know about this drug. The knowledge of the use of Ivermectin in the treatment of COVID-19 is high in 43.1% of the participants and medium in 21.7% indicating that the participants know about this drug.
Description
Keywords
Citation
Vancouver
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess
